EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Bristol Myers Squibb Company (BMY) had EBIT Margin of 11.77% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$12.50B |
|
$1.09B |
|
$4.10B |
|
$8.41B |
|
$11.03B |
|
$1.47B |
|
-- |
|
$1.47B |
|
$1.47B |
|
$1.09B |
|
$1.09B |
|
$1.09B |
|
$1.09B |
|
$1.47B |
|
$2.45B |
|
2.03B |
|
2.04B |
|
$0.54 |
|
$0.54 |
|
| Balance Sheet Financials | |
$29.39B |
|
$7.54B |
|
$60.65B |
|
$90.04B |
|
$23.42B |
|
$42.85B |
|
$48.12B |
|
$71.53B |
|
$18.51B |
|
$-22.35B |
|
$18.51B |
|
2.01B |
|
| Cash Flow Statement Financials | |
$14.16B |
|
$-4.13B |
|
$-10.35B |
|
$10.35B |
|
$10.22B |
|
$-129.00M |
|
$553.00M |
|
$-5.04B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.26 |
|
-- |
|
-- |
|
0.70 |
|
2.44 |
|
67.24% |
|
11.77% |
|
|
EBIT Margin |
11.77% |
-- |
|
11.76% |
|
8.69% |
|
$12.85B |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
1.52 |
|
1.10 |
|
82.17 |
|
5.87% |
|
-4.86% |
|
1.21% |
|
1.77% |
|
$9.19 |
|
$6.30 |
|
$6.94 |
|